Navigation Links
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008
Date:4/9/2008

he conversion rate was dose-dependent.

The Congressional briefing, sponsored by Congressman James Langevin (D-RI), provides an opportunity for members of Congress and their staff to meet with experts, hear a general overview of spinal cord research and to receive an update on the latest advancements and therapeutic interventions. Dr. Hurtt will be joined by Dr. Damien Pearse of the Miami Project, Dr. Stephen Davies, University of Colorado, Dr. Wise Young, Rutgers University and Dr. Simon Archibald, Integra LifeSciences.

Dr. Hurtt commented, "As we continue to develop CETHRIN with the aim of providing a first-ever therapeutic option for nerve repair to patients with acute spinal cord injury, we are committed to the support of the excellent work of the SCI advocacy groups. These groups reach out to patients, care-givers, professional societies and the general public providing valuable educational, quality of life and often research funding opportunities. We are most pleased to have been invited to the 'Working 2 Walk' Conference and to assist their legislative efforts in the U.S. Congress."

About Working 2 Walk

The third annual "Working 2 Walk" Conference to be held April 13-15, 2008 in Washington, DC is a joint project of Unite 2 Fight Paralysis, a nationwide patient advocacy organization, and the Kennedy Krieger Institute of Baltimore, leaders in rehabilitative strategies that restore function after spinal cord injury. The "Working 2 Walk" Science and Educational Symposium provides a setting for researchers, clinicians and the spinal cord injury community to collaborate on strategies necessary to achieve a cure for paralysis.

About Alseres

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... ALBANY, New York , August 20, 2014 /PRNewswire/ ... published a new market report titled "Monochloroacetic Acid (MCA) ... Other Applications - Global Industry Analysis, Size, Share, Growth, ... acid market was valued at USD 817.1 million in ... by 2020, growing at a CAGR of 3.6% during ...
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Advanced Wound Care and ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020" report to their offering. ... advanced wound care and closure market (types, applications, ...
(Date:8/20/2014)... 2014  Decision Resources Group finds that ... device market will expand through 2023 as ... fibrillation (AF). The increasing acceptance of ablation ... will spur adoption of premium-priced products designed ... loop diagnostic catheters, cryoablation catheters and contact ...
Breaking Medicine Technology:Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3
... Services, Inc. (NYSE: WST ) announced today that it ... opens on Tuesday, November 3, 2009 and will follow with ... at 9:00 a.m. Eastern Time. To participate on the call ... A live broadcast of the conference call will be available ...
... Inc. (NYSE: HSP ), a leading global specialty ... the third quarter ended Sept. 30, 2009. Net sales ... earnings per share were $0.90. (Adjusted* measures exclude certain ... and the attached schedules.) , "Hospira delivered strong results ...
Cached Medicine Technology:West to Host 2009 Third Quarter Conference Call 2Hospira Reports Third-Quarter 2009 Results 2Hospira Reports Third-Quarter 2009 Results 3Hospira Reports Third-Quarter 2009 Results 4Hospira Reports Third-Quarter 2009 Results 5Hospira Reports Third-Quarter 2009 Results 6Hospira Reports Third-Quarter 2009 Results 7Hospira Reports Third-Quarter 2009 Results 8Hospira Reports Third-Quarter 2009 Results 9Hospira Reports Third-Quarter 2009 Results 10Hospira Reports Third-Quarter 2009 Results 11Hospira Reports Third-Quarter 2009 Results 12Hospira Reports Third-Quarter 2009 Results 13Hospira Reports Third-Quarter 2009 Results 14Hospira Reports Third-Quarter 2009 Results 15Hospira Reports Third-Quarter 2009 Results 16Hospira Reports Third-Quarter 2009 Results 17Hospira Reports Third-Quarter 2009 Results 18Hospira Reports Third-Quarter 2009 Results 19Hospira Reports Third-Quarter 2009 Results 20Hospira Reports Third-Quarter 2009 Results 21Hospira Reports Third-Quarter 2009 Results 22Hospira Reports Third-Quarter 2009 Results 23Hospira Reports Third-Quarter 2009 Results 24Hospira Reports Third-Quarter 2009 Results 25Hospira Reports Third-Quarter 2009 Results 26Hospira Reports Third-Quarter 2009 Results 27Hospira Reports Third-Quarter 2009 Results 28
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Ticket Down ... Championship tickets in NYC. In just a week, the ... Jean King Tennis Center. The event was originally founded in 1881 ... event, Rafael Nadal was forced to withdrawal from the event because ... 2014 women’s tournament and will return to New York City with ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... rates fell dramatically during the past two decades, plummeting 57 ... report shows. An estimated 4 million fewer births occurred ... researchers from the U.S. Centers for Disease Control and Prevention. ... from the report," said Bill Albert, chief program officer of ...
(Date:8/20/2014)... patient and tumor characteristics for melanomas with higher ... in an effort to increase earlier detection of ... , Author: Sarah Shen, M.B.B.S., B.Med.Sci., of Alfred ... The tumor characteristic known as mitotic rate ... prognosis and survival in melanoma patients. However, the ...
(Date:8/20/2014)... of Adelaide researchers have discovered that the immune system ... is a major reason why sufferers have ongoing issues with ... in the world could also help to explain why ... Irritable bowel syndrome (IBS) affects up to 10% of the ... of them involve unexplained gut pain, which often has the ...
(Date:8/20/2014)... is now, Free content, The time to deploy ... being published early online today in Annals ... School of Public Health write that the relentless epidemiologic ... represent a public health crisis that shows no signs ... been developed in the last decade, yet the sporadic ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2
... By Madonna Behen HealthDay Reporter , MONDAY, ... take erectile dysfunction drugs such as Viagra are more likely ... than 1.4 million men finds. Researchers at Massachusetts General ... lies not with the drugs but rather the high risk ...
... 30 years of standardized test data from the very ... boys and girls have narrowed considerably, but boys still ... high levels of math ability and scientific reasoning. ... extremely high levels of verbal reasoning and writing ability. ...
... ... , ... 2010 -- “Today’s announcement of a new entity at the United Nations for women and ... Harnessing the United Nations’ collective power and authority to advance the rights and needs ...
... , ... Mist Ecology,s AC Spritzer Product and its Parent Company,s Entrepreneurial Engineers , ... (PRWEB) July 6, 2010 -- An engineer goes ... off. Some water splashes on his home,s air conditioning unit, and an idea for a ...
... Get fit with ... July 6-July 19 , ... July 6, 2010 – Onlineshoes.com and New Balance make it easy to get fit ... pedometer from July 6-July 19. (Read on to find out more about New Balance truebalance shoes ...
... ... Air Ambulance is pleased to announce the 2010 Angel MedFlight Scholarship of ... the recipient will receive $3,000 toward his or her tuition for an ... Angel MedFlight Scholarship for Excellence in Aviation only have two more weeks ...
Cached Medicine News:Health News:Drugs Like Viagra Linked to Higher Rates of STDs 2Health News:Drugs Like Viagra Linked to Higher Rates of STDs 3Health News:Gender gap persists at highest levels of math and science testing 2Health News:Gender gap persists at highest levels of math and science testing 3Health News:New UN Entity Strengthens Global Efforts for Women & Girls 2Health News:A/C Mist Device Cools Down Air Conditioners, Utility Bills 2Health News:A/C Mist Device Cools Down Air Conditioners, Utility Bills 3Health News:A/C Mist Device Cools Down Air Conditioners, Utility Bills 4Health News:Onlineshoes.com and New Balance Pair Up for Toning Shoes Giveaway 2Health News:Onlineshoes.com and New Balance Pair Up for Toning Shoes Giveaway 3Health News:Angel MedFlight Worldwide Air Ambulance offers,$3,000 scholarship for a student pursuing a career in aviation at an Arizona school, 2Health News:Angel MedFlight Worldwide Air Ambulance offers,$3,000 scholarship for a student pursuing a career in aviation at an Arizona school, 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: